Glaxosmithkline Pharmaceuticals Ltd Share Price

GlaxoSmithKline (GSK) Pharmaceuticals, a subsidiary of UK-based GSK plc, is a leading global biopharma company bringing together science, technology and talent to deliver impact and get ahead of disease together worldwide. For decades, it has been an important proponent of the ‘Make in India’ vision, delivering pioneering breakthroughs in medicines and vaccines that have prevented diseases and improved the quality of life for millions in the country. 

Its diverse product portfolio spans general medicines, specialty medicines and vaccines, addressing a broad spectrum of healthcare needs. From anti-infectives, pain management and dermatological products to advanced therapies in respiratory, to vaccines for adults and children, it harnesses scientific innovation and data-driven technologies to prevent and treat diseases effectively.

Business area of the company

The company is engaged in research, manufacture and making available a broad range of medicines and vaccines that benefit people. The company’s pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, its vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Products of the company

• Anti-Infectives 
• Pain Management
• Hormones
• Respiratory
• Dermatologicals
• Vitamins, Minerals, Nutritional products
• Vaccines

Awards and recognitions

2017: 

• Pharma & Medical Devices Summit & Excellence Awards 2017
• GSK India wins the Gold Award at the TISS - CLO Summit
• GSK India won the 'Gold award' in the Sales Enablement Category at the Tata Institute of Social Sciences (TISS) - CLO Summit in Mumbai.

2018:

• GSK ranked among the 50 best companies in India as per People Capital Index (PCI). GSK was conferred this recognition at the HR Leadership Summit 2018.
• GSK won the OPPI Salesforce Excellence Award 2018. The award recognises its efforts in launching and scaling an innovative, mobile based platform for sales readiness.
• Tbact bags the Silver award for ‘Brand of the Year - Acute category 2018’ for marketing excellence. This award is a testimony to Teamwork and accountability displayed by each member of the cross functional team associated with Tbact.
• The company has been recognised as one of the 100 Best Companies for Women by Working Mother and AVTAR. The award was received by members of the Women's Leadership Board.
• GSK topped the Access to Medicine Index (ATMI) for the sixth time in a row. ATMI is an independent measure of the top 20 pharmaceutical companies’ efforts to improve access to healthcare in developing countries.
• GSK's Corporate Communication and Government Affairs team was recognised by Reputation Today as the 30 Top Corporate Communication Teams in India.
• The company has been recognised as one of the 100 Best Companies for Women by Working Mother and AVTAR for the second time in a row. This is an important milestone in its inclusion and diversity journey.
  
• GSK has been recognised as the 'Best Workplaces for Women' by Great Places To Work in India. This award celebrates the efforts of the company's Women's Leadership Initiative towards creating an inclusive work environment.

2019:

• GSK won the 2019 D&I in India Best Practices Awards in the 'Advancement of Women' category by Community Business.
• GSK won the award for the 'Best Sales and Operations Planning Practice in Pharma' 2019.
• T-Bact won 'Brand of the Year' award in the acute category for the second consecutive year in 2019 at the 6th AWACS Awards for marketing excellence.

2020: 

• GSK was recognised as India’s Best Workplaces for Women 2020 by Great Places to Work.
• GSK was recognised as 100 Best Companies for Women in India 2020 by Working Mother and AVTAR.

Milestones

• 1924: Glaxo comes to India as H J Foster and Co.
• 1947: Secondary manufacturing of pharmaceuticals begins at Glaxo’s Worli plant.
• 1956: Primary production of vaccines begins at Worli plant.
• 1968: Glaxo is registered as Limited company.
• 1972: Scientists at Beecham Research laboratories discover Amoxycillin and launch Amoxil, which eventually becomes a widely used antibiotic.
• 1981: Augmentin was launched by Beecham to combat a wide range of bacterial infections in children and adults and the antiviral Zovirax was launched by Wellcome for harpes infections.
• 1983: Glaxo’s Nashik factory commissioned.
• 1999: Glaxo India completes 75 years in India.
• 2001: Legal merger of Glaxo India Limited and SmithKline Beecham Pharmaceuticals (India) Limited to form GlaxoSmithKline Pharmaceuticals Limited.
• 2015: GSK acquired Novartis vaccines business (excluding influenza vaccines).
• 2016: Launched Priorix- Tetra.
• 2018: Launched Infanrix Hexa.
• 2019: Launched Menveo (Quadrivalent Meningococcal Conjugate Vaccine).
• 2019: The company has launched Spectrum, an employee resource group for raising awareness on LGBT+ among the employees.
• 2019: Launched a development programme GSK WeLeAP - GSK Women Leadership Action Programme - to develop high potential mid-level women talent.
• 2021: GSK, PATH and Bharat Biotech sign product transfer agreement to help ensure long-term supply of ground-breaking malaria vaccine.
• 2022: GSK launches once daily, single inhaler-triple therapy for COPD patients for the first time in India.
• 2023: GSK launches Shingrix in India- A vaccine for the prevention of shingles in adults aged 50 years and above.
• 2023: Amitabh Bachchan partners with GSK for shingles awareness and prevention.
• 2024: GlaxoSmithKline Pharmaceuticals Limited crosses Rs 1000 crore in Revenue from Operations.
• 2025: GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers.